Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Sat Nusapersada Tbk (PTSN) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Sat Nusapersada TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Sat Nusapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Sat Nusapersada Tbk trades at Rp244 (market cap 1.29T, 620.7K 24h volume). The key difference: Sat Nusapersada Tbk is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 620.7K). Which is the better fit depends on your goals.

DGNSPTSN
Market Cap
310.75B1.29T
Volume
963.6K620.7K
Lot
9.64K6.21K
Turnover
217.67M151.23M
Average Price
225.89243.64
Value
217.67M151.23M
Indicative Equilibrium Price
226244
Indicative Equilibrium Volume
1K15

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PTSN
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Sat Nusapersada Tbk

Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.

Read more on PTSN